1. Duloxetine, a generic version of Eli Lilly’s drug Cymbalta, is used to treat major depressive disorder, general anxiety disorder and fibromyalgia.
2. Gocovri treats dyskinesia, a side effect of a medication prescribed to most Parkinson’s disease patients.
3. Kymriah uses patients’ genetically modified immune cells to fight relapsed acute lymphoblastic leukemia.
4. Vabomere is an intravenous antibacterial drug intended for adults with complicated urinary tract infections.
5. Benznidazole is the first FDA-approved treatment for Chagas disease in the U.S.
6. HeartMate 3 Left Ventricular Assist System pumps blood via a magnetically levitated propeller that simulates the beating of a heart.
7. Victoza may now be used to reduce the risk of cardiovascular events — like heart attacks and strokes — in type 2 diabetes patients.
More articles on supply chain:
Novartis, CMS collaborate on outcomes-based pricing for $465k leukemia drug
FDA approves Novartis’ ‘breakthrough’ leukemia drug — with a price tag of $475k
Abbott issues software update to prevent pacemaker hacks: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
